Draft guideline recommends limiting dosing to equivalent of 90 mg of morphine per day and limiting use to three days after acute injury.
The Centers for Disease Control and Prevention has developed a guideline for prescribing opioids for chronic pain that would limit dosage and duration and could potentially curb sales.
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Some advisory committee members said adding quantitative data on misuse, abuse, opioid use disorder and overdose to labeling would be helpful, but others worried the two epidemiological studies were not sufficiently generalizable to a broader population.
Viatris joined Hikma and Amneal, in signing agreements for cash settlements that resolve allegations its practices fueled the US’ deadly opioid epidemic.
Drugmakers are not expecting a big financial hit from tariffs for now, but a report commissioned by the industry trade association PhRMA suggests a potentially steep cost for pharma-sector tariffs.
